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Identification of Arboviruses and
Certain Rodent-Borne Viruses:
Reevaluation of the Paradigm
Diagnostic and epidemiologic virology laboratories have
in large part traded conventional techniques of virus
detection and identification for more rapid, novel, and
sensitive molecular methods. By doing so, useful phenotypic
characteristics are not being determined. We feel that the
impact of this shift in emphasis has impaired studies of the
biology of viruses. This position paper is a plea to the
scientific and administrative communities to reconsider the
importance of such information. We also suggest a revised
paradigm for virus isolation and characterization and
provide a rationale for accumulating biologic (phenotypic)
information.
Historical Background
Until about 10 years ago, arthropod-borne viruses
(arboviruses) were isolated and then identified by methods
now referred to as “classical.” That is, clinical or field-
collected samples were processed by methods originally
established by yellow fever researchers at the Rockefeller
Foundation (1-3). As these procedures were shared and
adopted by essentially all laboratories conducting arbovirus
surveillance and research, they became the standard for
arbovirus laboratories worldwide. These techniques were
developed to facilitate specific identification of viruses
isolated from hematophagous arthropods, vertebrate
animals, and human clinical samples. The general scheme
included a) isolation of the virus; b) production of a virus
seed or stock; c) production of a sucrose-acetone extracted
antigen (often inactivated so that it could be used safely for
serodiagnostic procedures); d) preparation of an antibody
(usually hyperimmune mouse ascitic fluids); e) registration
of the virus; and f) deposition of the virus as a voucher
specimen in a reference collection (3,4). The accumulation of
such reagents by arbovirus laboratories allowed the estab-
lishment of reference centers that, with the support and
encouragement of the World Health Organization (5,6) and
various national governments, distribute useful reagents to
regional and local laboratories. Local laboratories, in turn,
were then able to conduct serodiagnostic tests for antibody
to newly recognized arboviruses, using standardized
reagents for virus identification procedures. As an inten-
tional by-product, a network of collaborating centers was
established and an international spirit of cooperation and
camaraderie evolved, as exemplified by the American
Committee on Arthropod-Borne Viruses (ACAV) and its
various subcommittees that take responsibility for collating
a catalog of the recognized arthropod-borne and rodent-
associated viruses (7), evaluating their safety, storing
voucher specimens, and determining their antigenic
relationships. The resulting catalog, entitled The Interna-
tional Catalogue of Arboviruses and Certain Other Viruses
of Vertebrates, has long been the “bible” of arbovirologists.
However, with the availability of newer molecular tech-
niques and the current emphasis on genomics, many
viruses now are detected by molecular means only. Conse-
quently, few newly discovered viruses are now being
registered in the arbovirus catalog, although hundreds of
genomic sequences of arboviruses, hantaviruses,
arenaviruses, and filoviruses are entered annually in
GenBank or other sequence databases. The latter data
provide little or no phenotypic information, and, although
the ACAV is attempting to provide accessible online
biological information regarding arboviruses and other
viruses, progress has been slow, in part because of lack of
funding and perception of needs. The ultimate goal is to
merge genotypic information, such as that deposited in
sequence databases, with phenotypic and epidemiologic
information, such as that published in the arbovirus
catalog, and thereby provide a more accurate and complete
picture of the biological characteristics of each virus.
In the heyday of arbovirology (ca. 1960-1975), arbovirus
laboratories were fully functional in many parts of the
world and both government and institutional support was
high. The levels of training, reagent availability, virus
discovery, epidemiologic assessments, and research activi-
ties were likewise high. As new techniques were developed,
the name of the group studying arboviral antigenic relation-
ships was changed from the Subcommittee on Immunologi-
cal Relationships Among Catalogued Arboviruses to the
Subcommittee on InterRelationships Among Catalogued
Arboviruses (SIRACA), to reflect the introduction of molecu-
lar techniques as adjunct tools for virus identification and
characterization. Few could have predicted the rapid
advances to be made or the detail to which the arboviruses
would be characterized.
The Apparent Paradigm Shift
As newer techniques (monoclonal antibodies for specific
virus identification, immunohistochemistry, RNA finger-
printing, nucleic acid hybridization, and, in particular,
polymerase chain reaction and nucleic acid sequencing)
were introduced, the earlier techniques were replaced as
front-line diagnostic tests, although they remained ade-
quate for most purposes. One reason for this trend was that
nucleic acid sequencing and monoclonal antibody mapping
of proteins could be used for remarkably rapid and detailed
analyses of virus identities and structures by using re-
agents that had better production consistency and were
easier to standardize between laboratories. However, the
reliance on genomic sequencing for virus identification has
resulted in an apparent quandary: whether to use molecu-
lar or other methods for virus identification. Molecular
techniques provide information regarding genotypic charac-
teristics. Serologic techniques (hemagglutination inhibition,
complement fixation, immunofluorescence using polyclonal
or monoclonal antibodies, enzyme-linked immunosorbent
assay, neutralization, and vaccination challenge) provide
information regarding phenotype. These serologic tech-
niques provide insight into protection and cross-protection
against virus infection, information that is of essential
epidemiologic and public health significance.
Information Gained, Opportunities Lost
In reality, there is no quandary. Genotypic and pheno-
typic data are complementary; the phenotype is simply the
outward observable characteristic of a virus as determined
by its genotype. The genomic sequence provides the founda-
tion for phenotypic expression, but it is not yet possible to
deduce completely the phenotype of a virus solely from its
genomic sequence. Although some antigenic properties canCommentary
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be determined by using recombinant antigens, most
phenotypic characteristics of a virus (its host range,
pathogenicity, cell and tissue tropisms, replication charac-
teristics, and elicitation of protective immunity) still must
be determined directly. Because of this, SIRACA continues
to support the use of phenotypic assays to identify and
classify newly discovered viruses. It is not always necessary
to derive genome sequence information for appropriate
classification. In fact, for some arboviruses, e.g., those of the
families Bunyaviridae and Rhabdoviridae, so little genomic
sequence information exists that virus identification must
rely on serologic techniques.
Reasons To Accumulate Phenotypic Information
To accurately phenotype a newly discovered virus,
infectious virus must be available. Only with an actual
isolate is it possible to obtain normal antigenic and other
biologic information for comparison with the classical virus
databases that have been accrued over many decades.
Without a virus isolate, direct cross-protective assays
cannot be conducted, and therefore the interrelationships by
neutralization of newly recognized arboviruses, hantavirus-
es, arenaviruses, and filoviruses cannot be determined.
Cross-neutralization relationships have been the basis by
which most of these viruses have been classified and
differentiated (8-15).
Recently, sequencing of virus genomes has opened the
fields of viral phylogenetics and molecular epidemiology,
allowing comparisons not possible by the older, classical
methods. It is now possible to determine rapidly and with
some certainty the sources of viruses causing dengue fever
(16), West Nile fever (17,18), Venezuelan equine encephali-
tis (19), hantavirus pulmonary syndrome (20), Ebola fever
(21), and outbreaks caused by many other viruses (22). Still,
procedures appear to have outpaced process in the study of
emerging and reemerging virus diseases.
New Technology Creates New Problems
Detection of viral nucleic acid is not equivalent to
isolating a virus. Some hantaviruses have been detected,
sequenced and placed in a taxon, and the proteins of some
have been expressed without the viruses having been
isolated (23). Newly recognized hantaviruses have been
described solely on the basis of genomic sequencing, without
the agent ever being isolated or the appropriate phenotyp-
ing reagents being produced (24-26). Without an isolate, the
pathogenic potential, association with human infections and
illnesses, and cross-protectivity are difficult to assess. One
of the reasons for this development is that agencies funding
virus research have opted to support mainly molecular and
genetic studies. This funding decision has had a direct
effect on the type of virus research carried out at universi-
ties, as well as direct and indirect effects on faculty recruit-
ment and graduate education. Research involving the new
genetic technologies is promoted as “cutting edge” and
“mechanistic,” while more classical phenotypic studies are
referred to somewhat disparagingly as “descriptive.” In
truth, both types of research are largely descriptive; genome
sequencing and phylogenetic studies of viruses are the
molecular equivalents of classical (phenotypic) studies of
antigenic properties and antigenic interrelationships.
However, both types of research are essential to our
understanding of the mechanisms of viral pathogenesis,
disease expression, and protective immunity.
Another reason for the lack of phenotypic information
about most newly discovered viral pathogens is the in-
creased number of restraints and regulations on the
importation, use, and exchange of infectious viruses. The
result has been to severely restrict their study to a relative-
ly few high-security laboratories. Inactivated RNA or DNA
samples of such agents can be obtained without the need for
permits, which favors the use of molecular or genetic
methods for studying new viruses. The filoviruses are a case
in point. These viruses are extremely hazardous and must
be handled under strict Biosafety Level 4 containment.
Little is known about their antigenic interrelationships,
cross-protectivities, and biological characteristics. Because
of the hazards posed by working with these viruses, this is
likely to remain the case for the foreseeable future. In
contrast, nucleotide sequence analyses of filoviruses provide
information adequate for epidemiologic and diagnostic
purposes, as well as for phylogenetic studies. Such analyses
cannot provide antigenic information for group placement
(classification) by neutralization tests or tell us much about
pathogenesis or protection. However, in view of their
hazardous nature, it would seem prudent for most laborato-
ries to continue assaying filoviruses by molecular tech-
niques, rather than to attempt direct virus isolation.
Despite the remarkable advances in sequencing and
phylogenetic analysis, there still is little agreement on the
standardization of sequencing approaches, which portions of
the genomes of these agents are “best” for designing
primers for amplification and diagnostic purposes, and
which genome regions will provide the most useful sequence
information for taxonomic purposes (for example, the gene
coding for the expression of an immunodominant epitope).
Uniformity is the sine qua non of such comparisons.
Other issues also impact biological characterization of
viruses. For example, little funding is available for the
study of animal viruses that are not known or suspected to
be pathogens of humans, livestock, or wildlife. The current
system of research support in the United States does not
encourage the study of orphan viruses until they emerge as
proven pathogens, a significant departure from the previous
longstanding and productive policy. Likewise, funding
agencies have little interest in supporting field studies
designed to isolate and identify new viruses. Much lip
service is given to the need for biological inventories of
species diversity (genetic resources), but in the case of
viruses, little funding is available for such studies. As
noted, restrictions on the shipment and exchange of some
infectious agents, because of biosafety and bioterrorism
concerns, have inhibited biological studies with many
viruses. Further discussions of these issues are beyond the
scope of this paper.
A Solution?
SIRACA continues to emphasize the need for new virus
isolates for reference and antigenic studies and for reagent
production, even when such isolates are difficult to retrieve.
We emphasize that the sources of new arboviruses, hantavi-
ruses, arenaviruses, and filoviruses are field materials, not
laboratories. Without support for continued field studies
and continued virus isolation, including long-term storageCommentary
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of representative virus isolates, our knowledge of viral
ecology, evolution, and disease emergence will continue to
suffer.
In summary, remarkable advances in molecular
genetics have allowed rapid and precise identifications of
viruses and of their genomes; however, such characteriza-
tions thus far can provide only limited information about
the phenotype and disease potential of a virus. In addition
to more support for studies of viral ecology, pathogenesis,
and disease potential, there is a need for serologic reagents
with which classical studies can be done. We suggest that
infectious materials, in the form of seed virus, be submitted
to reference repositories, such as those at the University of
Texas Medical Branch, Galveston, Texas; the Division of
Vector-Borne Infectious Diseases, Centers for Disease
Control and Prevention, Fort Collins, Colorado; and the
Institut Pasteur, Paris, France. These and other reference
centers are supported by home institutions, government
agencies, and other funding sources and serve as reposito-
ries, rather like museums without the dust.
We suggest that viruses, not simply their genomes, be
registered with ACAV, the specialty group on which the
International Committee for Taxonomy of Viruses mainly
depends for classification of the arboviruses, hantaviruses,
arenaviruses, and filoviruses. Financial and enthusiastic
and knowledgeable administrative support is needed to
continue the task of updating the arbovirus catalog and
making it available electronically. As with disease diagno-
sis, it is the process, not the procedure, that is critical to
success.
American Committee on Arthropod-borne Viruses,
Subcommittee on InterRelationships Among
Catalogued Arboviruses1
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